Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit...
Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit from immunotherapy
About this item
Full title
Author / Creator
Publisher
England: Future Medicine Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
A minority of patients gains advantage from immunotherapy (IO). Predictive variables of long-term benefit (LTB) are incompletely understood.
We retrospectively collected data about metastatic non-small-cell lung cancer patients treated with IO from April 2013 to July 2017. We defined LTB to IO as complete response (CR), partial response (PR) or...
Alternative Titles
Full title
Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit from immunotherapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2263321192
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2263321192
Other Identifiers
ISSN
1479-6694
E-ISSN
1744-8301
DOI
10.2217/fon-2019-0055
